Caressa Hui

Also affiliated with Stanford University

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CNS Control after First-Line Osimertinib in Patients with Metastatic EGFR-Mutant NSCLC”.

CNS Control after First-Line Osimertinib in Patients with Metastatic EGFR-Mutant NSCLC

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.888

N/A

0DataRank · unranked

0 citations

Heather A. Wakelee, Joel W. Neal, Kavitha Ramchandran, Millie Das, Seema Nagpal +5 more

Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene–Driven Non–Small Cell Lung Cancer (TURBO-NSCLC)

Journal of Clinical Oncology(2024)10.1200/jco.23.02668

N/A

0DataRank · unranked

49 citations

Emily Miao, Lillian A. Boe, Tejas Patil, Brandon S. Imber, Nathaniel J. Myall +19 more

Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100914

N/A

0DataRank · unranked

0 citations

Caressa Hui, Joel W. Neal, Seema Nagpal, Mohana Roy, Millie Das +6 more